نيتازوكسانيد: الفرق بين النسختين

أُضيف 1٬031 بايت ، ‏ قبل 11 شهرًا
لا يوجد ملخص تحرير
(روبوت - إضافة لشريط البوابات :بوابة:طب)
لا ملخص تعديل
}}
 
'''نيتازوكسانيد'''<ref>{{استشهاد ويب
'''نيتازوكسانيد''' {{إنج|Nitazoxanide}} هو [[دواء]] يُستعمل في [[علاج (طب)|علاج]]:<ref name="Broad-spectrum antiviral review">{{cite journal | vauthors = Rossignol JF | title = Nitazoxanide: a first-in-class broad-spectrum antiviral agent | journal = Antiviral Res. | volume = 110 | issue = | pages = 94–103 | date = October 2014 | pmid = 25108173 | doi = 10.1016/j.antiviral.2014.07.014 | quote = Originally developed and commercialized as an antiprotozoal agent, nitazoxanide was later identified as a first-in-class broad-spectrum antiviral drug and has been repurposed for the treatment of influenza.&nbsp;... From a chemical perspective, nitazoxanide is the scaffold for a new class of drugs called thiazolides. These small-molecule drugs target host-regulated processes involved in viral replication.&nbsp;... A new dosage formulation of nitazoxanide is presently undergoing global Phase 3 clinical development for the treatment of influenza. Nitazoxanide inhibits a broad range of influenza A and B viruses including influenza A(pH1N1) and the avian A(H7N9) as well as viruses that are resistant to neuraminidase inhibitors.&nbsp;... Nitazoxanide also inhibits the replication of a broad range of other RNA and DNA viruses including respiratory syncytial virus, parainfluenza, coronavirus, rotavirus, norovirus, hepatitis B, hepatitis C, dengue, yellow fever, Japanese encephalitis virus and human immunodeficiency virus in cell culture assays. Clinical trials have indicated a potential role for thiazolides in treating rotavirus and norovirus gastroenteritis and chronic hepatitis B and chronic hepatitis C. Ongoing and future clinical development is focused on viral respiratory infections, viral gastroenteritis and emerging infections such as dengue fever.}}</ref><ref name="Thiazolides">{{cite journal | vauthors = Di Santo N, Ehrisman J | title = Research perspective: potential role of nitazoxanide in ovarian cancer treatment. Old drug, new purpose? | journal = Cancers (Basel) | volume = 5 | issue = 3 | pages = 1163–1176 | year = 2013 | pmid = 24202339 | pmc = 3795384 | doi = 10.3390/cancers5031163 | quote = Nitazoxanide [NTZ: 2-acetyloxy-N-(5-nitro-2-thiazolyl)benzamide] is a thiazolide antiparasitic agent with excellent activity against a wide variety of protozoa and helminths. &nbsp;... Nitazoxanide (NTZ) is a main compound of a class of broad-spectrum anti-parasitic compounds named thiazolides. It is composed of a nitrothiazole-ring and a salicylic acid moiety which are linked together by an amide bond&nbsp;... NTZ is generally well tolerated, and no significant adverse events have been noted in human trials [13].&nbsp;... In vitro, NTZ and tizoxanide function against a wide range of organisms, including the protozoal species Blastocystis hominis, C. parvum, Entamoeba histolytica, G. lamblia and Trichomonas vaginalis [13]}}</ref><ref name="Nitazoxanide: Broad-spectrum antiparasitic">{{cite journal | vauthors = White CA | title = Nitazoxanide: a new broad spectrum antiparasitic agent | journal = Expert Rev Anti Infect Ther | volume = 2 | issue = 1 | pages = 43–9 | year = 2004 | pmid = 15482170 | doi = 10.1586/14787210.2.1.43| quote = }}</ref>
| url = https://www.altebby.com/نيتازوكسانيد-nitazoxanide/
| title = نيتازوكسانيد Nitazoxanide
| date = 2018-07-26
| website = الدليل الطبي Altebby
| language = ar
| accessdate = 2021-06-13
'''نيتازوكسانيد'''}}</ref> {{إنج|Nitazoxanide}} هو [[دواء]] يُستعمل في [[علاج (طب)|علاج]]:<ref name="Broad-spectrum antiviral review">{{cite journal | vauthors = Rossignol JF | title = Nitazoxanide: a first-in-class broad-spectrum antiviral agent | journal = Antiviral Res. | volume = 110 | issue = | pages = 94–103 | date = October 2014 | pmid = 25108173 | doi = 10.1016/j.antiviral.2014.07.014 | quote = Originally developed and commercialized as an antiprotozoal agent, nitazoxanide was later identified as a first-in-class broad-spectrum antiviral drug and has been repurposed for the treatment of influenza.&nbsp;... From a chemical perspective, nitazoxanide is the scaffold for a new class of drugs called thiazolides. These small-molecule drugs target host-regulated processes involved in viral replication.&nbsp;... A new dosage formulation of nitazoxanide is presently undergoing global Phase 3 clinical development for the treatment of influenza. Nitazoxanide inhibits a broad range of influenza A and B viruses including influenza A(pH1N1) and the avian A(H7N9) as well as viruses that are resistant to neuraminidase inhibitors.&nbsp;... Nitazoxanide also inhibits the replication of a broad range of other RNA and DNA viruses including respiratory syncytial virus, parainfluenza, coronavirus, rotavirus, norovirus, hepatitis B, hepatitis C, dengue, yellow fever, Japanese encephalitis virus and human immunodeficiency virus in cell culture assays. Clinical trials have indicated a potential role for thiazolides in treating rotavirus and norovirus gastroenteritis and chronic hepatitis B and chronic hepatitis C. Ongoing and future clinical development is focused on viral respiratory infections, viral gastroenteritis and emerging infections such as dengue fever.}}</ref><ref name="Thiazolides">{{cite journal | vauthors = Di Santo N, Ehrisman J | title = Research perspective: potential role of nitazoxanide in ovarian cancer treatment. Old drug, new purpose? | journal = Cancers (Basel) | volume = 5 | issue = 3 | pages = 1163–1176 | year = 2013 | pmid = 24202339 | pmc = 3795384 | doi = 10.3390/cancers5031163 | quote = Nitazoxanide [NTZ: 2-acetyloxy-N-(5-nitro-2-thiazolyl)benzamide] is a thiazolide antiparasitic agent with excellent activity against a wide variety of protozoa and helminths. &nbsp;... Nitazoxanide (NTZ) is a main compound of a class of broad-spectrum anti-parasitic compounds named thiazolides. It is composed of a nitrothiazole-ring and a salicylic acid moiety which are linked together by an amide bond&nbsp;... NTZ is generally well tolerated, and no significant adverse events have been noted in human trials [13].&nbsp;... In vitro, NTZ and tizoxanide function against a wide range of organisms, including the protozoal species Blastocystis hominis, C. parvum, Entamoeba histolytica, G. lamblia and Trichomonas vaginalis [13]}}</ref><ref name="Nitazoxanide: Broad-spectrum antiparasitic">{{cite journal | vauthors = White CA | title = Nitazoxanide: a new broad spectrum antiparasitic agent | journal = Expert Rev Anti Infect Ther | volume = 2 | issue = 1 | pages = 43–9 | year = 2004 | pmid = 15482170 | doi = 10.1586/14787210.2.1.43| quote = }}</ref>
* [[داء خفيات الأبواغ]]<ref name="مولد تلقائيا1">{{استشهاد ويب
|عمل =المصطلحات المرجعية بملف العقاقير الوطني
| مسار أرشيف = https://web.archive.org/web/20190530054305/http://bioportal.bioontology.org/ontologies/NDFRT?p=classes | تاريخ أرشيف = 30 مايو 2019 }}</ref>
*[[داء الجيارديات]]<ref name="مولد تلقائيا1" />
 
== دواعي الاستعمال ==
 
* علاج داء الأميبات Amebiasis.
* علاج داء خفيات الأبواغ المعوي (كريبتوسبوريديوم) Cryptosporidiosis.
* علاج داء الجيارديات (حمى القندس) Giardiasis.
* علاج الاسهال نتيجة عدوى الكلوستريديوم ديفيسيل (التهاب القولون الغشائي الكاذب).
* علاج العدوى البكتيرية بالملوية البوابية (الجرثومة الحلزونية) .
* علاج داء الأسكارس Ascariasis عند الأطفال الأطفال.
* علاج داء الدودة الشريطية القزمة.
 
== موانع الاستعمال ==
 
* حساسية المفرطة تجاه الدواء.
 
==دوره==
يلعب هذا الدواء دورًا في علاج [[مرض|الأمراض]] كونه:<ref>{{استشهاد ويب
813

تعديل